Artelo Reports ART27.13 Weight Loss in Mice While Stock Drops 23%
Artelo Biosciences shares fell 23 percent despite the biotechnology firm reporting significant weight loss results in a preclinical animal model using its proprietary drug candidate ART27.13. The market pullback highlights ... Read More